Skip to main content

Table 2 Odds ratios for co-prescription of anti-diabetes agents and mood stabilizers.

From: Co-prescription of medication for bipolar disorder and diabetes mellitus: a nationwide population-based study with focus on gender differences

 

Total

 

Male

Female

  

Drugs

OR

CI (95%)

OR

CI (95%)

OR

Cl (95%)

Lamotrigine and insulin

1.8

(1.3, 2.5)

1.8

(1.3, 2.4)

1.7

(1.3, 2.1)

Carbamazepine and insulin

2.0

(1.3, 3.2)

3.0

(1.9, 4.8)

2.4

(1.8, 3.4)

Lithium and insulin

1.4

(1.0, 1.9)

1.6

(1.1, 2.2)

1.4

(1.1, 1.8)

Valproate and insulin

1.6

(1.1, 2.3)

2.6

(1.8, 3.7)

2.0

(1.5, 2.6)

Lamotrigine and oral antidiabetics

1.3

(1.0, 1.7)

1.8

(1.5, 2.3)

1.6

(1.3, 1.9)

Carbamazepine and oral antidiabetics

1.8

(1.3, 2.5)

2.6

(1.8, 3.6)

2.1

(1.7, 2.7)

Lithium and oral antidiabetics

1.5

(1.2, 1.8)

2.6

(2.2, 3.0)

1.9

(1.7, 2.2)

Valproate and oral antidiabetics

2.4

(1.9, 3.0)

3.0

(2.3, 3.7)

2.6

(2.2, 3.1)

  1. Odds ratios, with 95% CI, for using different mood stabilizers, combined or in in monotherapy for persons using anti-diabetes agents in monotherapy compared to the non diabetic population (divided into genders).